JPH09500014A - 菌類のタンパク質ジスルフィドイソメラーゼ - Google Patents
菌類のタンパク質ジスルフィドイソメラーゼInfo
- Publication number
- JPH09500014A JPH09500014A JP7502358A JP50235895A JPH09500014A JP H09500014 A JPH09500014 A JP H09500014A JP 7502358 A JP7502358 A JP 7502358A JP 50235895 A JP50235895 A JP 50235895A JP H09500014 A JPH09500014 A JP H09500014A
- Authority
- JP
- Japan
- Prior art keywords
- enzyme
- protein disulfide
- protein
- seq
- disulfide isomerase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 102000006010 Protein Disulfide-Isomerase Human genes 0.000 title claims abstract description 127
- 108010058643 Fungal Proteins Proteins 0.000 title abstract description 7
- 108020003519 protein disulfide isomerase Proteins 0.000 claims abstract description 125
- 238000004519 manufacturing process Methods 0.000 claims abstract description 16
- 241000228212 Aspergillus Species 0.000 claims abstract description 13
- 241000233866 Fungi Species 0.000 claims abstract description 13
- 108090000623 proteins and genes Proteins 0.000 claims description 65
- 102000004190 Enzymes Human genes 0.000 claims description 64
- 108090000790 Enzymes Proteins 0.000 claims description 64
- 210000004027 cell Anatomy 0.000 claims description 54
- 229940088598 enzyme Drugs 0.000 claims description 54
- 238000000034 method Methods 0.000 claims description 51
- 108020004414 DNA Proteins 0.000 claims description 48
- 102000004169 proteins and genes Human genes 0.000 claims description 48
- 235000018102 proteins Nutrition 0.000 claims description 47
- 150000001413 amino acids Chemical class 0.000 claims description 34
- 239000000203 mixture Substances 0.000 claims description 27
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 26
- 241000209094 Oryza Species 0.000 claims description 19
- 230000000694 effects Effects 0.000 claims description 19
- 239000013598 vector Substances 0.000 claims description 15
- 241000282414 Homo sapiens Species 0.000 claims description 12
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 10
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 claims description 9
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims description 9
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims description 9
- 210000004209 hair Anatomy 0.000 claims description 9
- 241000228245 Aspergillus niger Species 0.000 claims description 8
- 230000002538 fungal effect Effects 0.000 claims description 8
- 239000013604 expression vector Substances 0.000 claims description 7
- 229920001184 polypeptide Polymers 0.000 claims description 7
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 7
- 241000894006 Bacteria Species 0.000 claims description 6
- 241001465754 Metazoa Species 0.000 claims description 6
- 108010065511 Amylases Proteins 0.000 claims description 5
- 108091005804 Peptidases Proteins 0.000 claims description 5
- 102000035195 Peptidases Human genes 0.000 claims description 5
- 238000010367 cloning Methods 0.000 claims description 5
- 150000002019 disulfides Chemical class 0.000 claims description 5
- 102000013142 Amylases Human genes 0.000 claims description 4
- 235000019418 amylase Nutrition 0.000 claims description 4
- 230000001580 bacterial effect Effects 0.000 claims description 4
- 235000013305 food Nutrition 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 239000000523 sample Substances 0.000 claims description 4
- 239000004365 Protease Substances 0.000 claims description 3
- 229940025131 amylases Drugs 0.000 claims description 3
- 239000004744 fabric Substances 0.000 claims description 3
- 239000010985 leather Substances 0.000 claims description 3
- 230000000813 microbial effect Effects 0.000 claims description 3
- 235000015927 pasta Nutrition 0.000 claims description 3
- 238000003259 recombinant expression Methods 0.000 claims description 3
- 208000002177 Cataract Diseases 0.000 claims description 2
- 241000223218 Fusarium Species 0.000 claims description 2
- 108010068370 Glutens Proteins 0.000 claims description 2
- 108090001060 Lipase Proteins 0.000 claims description 2
- 102000004882 Lipase Human genes 0.000 claims description 2
- 239000004367 Lipase Substances 0.000 claims description 2
- 108700020962 Peroxidase Proteins 0.000 claims description 2
- 102000003992 Peroxidases Human genes 0.000 claims description 2
- 241000235070 Saccharomyces Species 0.000 claims description 2
- 239000003599 detergent Substances 0.000 claims description 2
- 125000002228 disulfide group Chemical group 0.000 claims description 2
- 230000001747 exhibiting effect Effects 0.000 claims description 2
- 235000021312 gluten Nutrition 0.000 claims description 2
- 235000019421 lipase Nutrition 0.000 claims description 2
- 230000000087 stabilizing effect Effects 0.000 claims description 2
- 230000008719 thickening Effects 0.000 claims description 2
- 210000005253 yeast cell Anatomy 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 3
- 101710167800 Capsid assembly scaffolding protein Proteins 0.000 claims 2
- 101710130420 Probable capsid assembly scaffolding protein Proteins 0.000 claims 2
- 102000001708 Protein Isoforms Human genes 0.000 claims 2
- 108010029485 Protein Isoforms Proteins 0.000 claims 2
- 101710204410 Scaffold protein Proteins 0.000 claims 2
- 241000193830 Bacillus <bacterium> Species 0.000 claims 1
- 108010059892 Cellulase Proteins 0.000 claims 1
- 102000010911 Enzyme Precursors Human genes 0.000 claims 1
- 108010062466 Enzyme Precursors Proteins 0.000 claims 1
- 241000588722 Escherichia Species 0.000 claims 1
- 244000043158 Lens esculenta Species 0.000 claims 1
- 229940106157 cellulase Drugs 0.000 claims 1
- 230000035617 depilation Effects 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000001681 protective effect Effects 0.000 claims 1
- 230000017854 proteolysis Effects 0.000 claims 1
- 230000003248 secreting effect Effects 0.000 claims 1
- 241000894007 species Species 0.000 claims 1
- 108060008226 thioredoxin Proteins 0.000 description 25
- 102000002933 Thioredoxin Human genes 0.000 description 22
- 239000012634 fragment Substances 0.000 description 15
- 240000006439 Aspergillus oryzae Species 0.000 description 14
- 239000000047 product Substances 0.000 description 13
- 235000001014 amino acid Nutrition 0.000 description 12
- 229940024606 amino acid Drugs 0.000 description 12
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 11
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 11
- 239000013612 plasmid Substances 0.000 description 11
- 108020004705 Codon Proteins 0.000 description 10
- 125000000539 amino acid group Chemical group 0.000 description 10
- 102220201851 rs143406017 Human genes 0.000 description 10
- 238000003752 polymerase chain reaction Methods 0.000 description 9
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 7
- 101150070377 PDI gene Proteins 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000002299 complementary DNA Substances 0.000 description 7
- 239000002265 redox agent Substances 0.000 description 6
- 230000009466 transformation Effects 0.000 description 6
- 241000287828 Gallus gallus Species 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- 108020004511 Recombinant DNA Proteins 0.000 description 5
- 108020004707 nucleic acids Proteins 0.000 description 5
- 102000039446 nucleic acids Human genes 0.000 description 5
- 150000007523 nucleic acids Chemical class 0.000 description 5
- 229940081969 saccharomyces cerevisiae Drugs 0.000 description 5
- 235000014469 Bacillus subtilis Nutrition 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- 108091034117 Oligonucleotide Proteins 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 239000011543 agarose gel Substances 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000002773 nucleotide Substances 0.000 description 4
- 125000003729 nucleotide group Chemical group 0.000 description 4
- 230000010076 replication Effects 0.000 description 4
- 108010001535 sulfhydryl oxidase Proteins 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 244000063299 Bacillus subtilis Species 0.000 description 3
- 240000004658 Medicago sativa Species 0.000 description 3
- 101100182721 Mus musculus Ly6e gene Proteins 0.000 description 3
- 238000012408 PCR amplification Methods 0.000 description 3
- 241000700157 Rattus norvegicus Species 0.000 description 3
- 102100036407 Thioredoxin Human genes 0.000 description 3
- 108090000637 alpha-Amylases Proteins 0.000 description 3
- 102000004139 alpha-Amylases Human genes 0.000 description 3
- 229940024171 alpha-amylase Drugs 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 239000013613 expression plasmid Substances 0.000 description 3
- 238000009396 hybridization Methods 0.000 description 3
- 238000005342 ion exchange Methods 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 229940124276 oligodeoxyribonucleotide Drugs 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 238000010561 standard procedure Methods 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- 210000002268 wool Anatomy 0.000 description 3
- 101150025017 440 gene Proteins 0.000 description 2
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 2
- 241001598984 Bromius obscurus Species 0.000 description 2
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 102000004195 Isomerases Human genes 0.000 description 2
- 108090000769 Isomerases Proteins 0.000 description 2
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 2
- 241000699660 Mus musculus Species 0.000 description 2
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 2
- 238000012300 Sequence Analysis Methods 0.000 description 2
- 238000002105 Southern blotting Methods 0.000 description 2
- 108010006785 Taq Polymerase Proteins 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- -1 amyL Chemical class 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000003527 eukaryotic cell Anatomy 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 239000002751 oligonucleotide probe Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000008488 polyadenylation Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 210000001938 protoplast Anatomy 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 125000003396 thiol group Chemical group [H]S* 0.000 description 2
- 229940094937 thioredoxin Drugs 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 241001515965 unidentified phage Species 0.000 description 2
- 101150056632 1.6 gene Proteins 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 101710097567 12 kDa protein Proteins 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000193375 Bacillus alcalophilus Species 0.000 description 1
- 241000193752 Bacillus circulans Species 0.000 description 1
- 241000193749 Bacillus coagulans Species 0.000 description 1
- 241000193422 Bacillus lentus Species 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- 108010029675 Bacillus licheniformis alpha-amylase Proteins 0.000 description 1
- 241000194107 Bacillus megaterium Species 0.000 description 1
- 241000193364 Bacillus thuringiensis serovar thuringiensis Species 0.000 description 1
- 108091005658 Basic proteases Proteins 0.000 description 1
- 101001072209 Bos taurus Protein disulfide-isomerase Proteins 0.000 description 1
- 241000193764 Brevibacillus brevis Species 0.000 description 1
- 101100208421 Candida albicans (strain SC5314 / ATCC MYA-2876) TMP1 gene Proteins 0.000 description 1
- 108010084185 Cellulases Proteins 0.000 description 1
- 102000005575 Cellulases Human genes 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- 101800004637 Communis Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 101100342470 Dictyostelium discoideum pkbA gene Proteins 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- 101100385973 Escherichia coli (strain K12) cycA gene Proteins 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241000223221 Fusarium oxysporum Species 0.000 description 1
- 241001149959 Fusarium sp. Species 0.000 description 1
- 101100001650 Geobacillus stearothermophilus amyM gene Proteins 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- 102100022624 Glucoamylase Human genes 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 101100295959 Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) arcB gene Proteins 0.000 description 1
- 101100182720 Homo sapiens LY6E gene Proteins 0.000 description 1
- 102220547770 Inducible T-cell costimulator_A23L_mutation Human genes 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 102100032131 Lymphocyte antigen 6E Human genes 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 235000010624 Medicago sativa Nutrition 0.000 description 1
- 101710164418 Movement protein TGB2 Proteins 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000194109 Paenibacillus lautus Species 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 108030003943 Protein-disulfide reductases Proteins 0.000 description 1
- 241000235403 Rhizomucor miehei Species 0.000 description 1
- 101000968489 Rhizomucor miehei Lipase Proteins 0.000 description 1
- 101710184528 Scaffolding protein Proteins 0.000 description 1
- 241000235346 Schizosaccharomyces Species 0.000 description 1
- 101100153788 Schizosaccharomyces pombe (strain 972 / ATCC 24843) tpx1 gene Proteins 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 241000187432 Streptomyces coelicolor Species 0.000 description 1
- 241000187398 Streptomyces lividans Species 0.000 description 1
- 101150048440 TSA1 gene Proteins 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 101100157012 Thermoanaerobacterium saccharolyticum (strain DSM 8691 / JW/SL-YS485) xynB gene Proteins 0.000 description 1
- 101100002024 Thermus aquaticus pstI gene Proteins 0.000 description 1
- QPMSXSBEVQLBIL-CZRHPSIPSA-N ac1mix0p Chemical compound C1=CC=C2N(C[C@H](C)CN(C)C)C3=CC(OC)=CC=C3SC2=C1.O([C@H]1[C@]2(OC)C=CC34C[C@@H]2[C@](C)(O)CCC)C2=C5[C@]41CCN(C)[C@@H]3CC5=CC=C2O QPMSXSBEVQLBIL-CZRHPSIPSA-N 0.000 description 1
- 108010048241 acetamidase Proteins 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 101150069003 amdS gene Proteins 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 101150008194 argB gene Proteins 0.000 description 1
- 210000004507 artificial chromosome Anatomy 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- 238000000376 autoradiography Methods 0.000 description 1
- 229940054340 bacillus coagulans Drugs 0.000 description 1
- 230000010310 bacterial transformation Effects 0.000 description 1
- 108010058966 bacteriophage T7 induced DNA polymerase Proteins 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
- 101150005799 dagA gene Proteins 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000006471 dimerization reaction Methods 0.000 description 1
- 150000004662 dithiols Chemical class 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000009144 enzymatic modification Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000008571 general function Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 235000020191 long-life milk Nutrition 0.000 description 1
- 101150039489 lysZ gene Proteins 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 101150095344 niaD gene Proteins 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- RGCLLPNLLBQHPF-HJWRWDBZSA-N phosphamidon Chemical compound CCN(CC)C(=O)C(\Cl)=C(/C)OP(=O)(OC)OC RGCLLPNLLBQHPF-HJWRWDBZSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 238000002708 random mutagenesis Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 101150110790 xylB gene Proteins 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 239000007206 ypm medium Substances 0.000 description 1
Classifications
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M16/00—Biochemical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. enzymatic
- D06M16/003—Biochemical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. enzymatic with enzymes or microorganisms
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
- A21D8/00—Methods for preparing or baking dough
- A21D8/02—Methods for preparing dough; Treating dough prior to baking
- A21D8/04—Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes
- A21D8/042—Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes with enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/14—Pretreatment of feeding-stuffs with enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/06—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y503/00—Intramolecular oxidoreductases (5.3)
- C12Y503/04—Intramolecular oxidoreductases (5.3) transposing S-S bonds (5.3.4)
- C12Y503/04001—Protein disulfide-isomerase (5.3.4.1), i.e. disufide bond-forming enzyme
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Textile Engineering (AREA)
- General Chemical & Material Sciences (AREA)
- Physiology (AREA)
- Animal Husbandry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK93768A DK76893D0 (OSRAM) | 1993-06-28 | 1993-06-28 | |
| DK0768/93 | 1993-06-28 | ||
| PCT/DK1994/000266 WO1995000636A1 (en) | 1993-06-28 | 1994-06-28 | A fungal protein disulfide isomerase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH09500014A true JPH09500014A (ja) | 1997-01-07 |
Family
ID=8097335
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP7502358A Ceased JPH09500014A (ja) | 1993-06-28 | 1994-06-28 | 菌類のタンパク質ジスルフィドイソメラーゼ |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US5879664A (OSRAM) |
| EP (1) | EP0708825A1 (OSRAM) |
| JP (1) | JPH09500014A (OSRAM) |
| AU (1) | AU7068494A (OSRAM) |
| DK (1) | DK76893D0 (OSRAM) |
| WO (1) | WO1995000636A1 (OSRAM) |
Families Citing this family (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK76893D0 (OSRAM) * | 1993-06-28 | 1993-06-28 | Novo Nordisk As | |
| WO1996011285A1 (en) * | 1994-10-07 | 1996-04-18 | Novo Nordisk A/S | A method for processing of hides or skins into leather, comprising enzymatic treatment of the hide or skin with a trypsin acting microbial protease |
| MX9703669A (es) * | 1994-12-21 | 1997-08-30 | Novo Nordisk As | Metodo para la depilacion de cueros o pieles por medio de enzimas. |
| US6248872B1 (en) * | 1996-12-03 | 2001-06-19 | Heska Corporation | Parasitic nematode transglutaminase, nucleic acid molecules, and uses thereof |
| US6383774B1 (en) * | 1996-12-03 | 2002-05-07 | Heska Corporation | Parasitic nematode transglutaminase, nucleic acid molecules and uses thereof |
| SE9704494D0 (sv) | 1997-12-02 | 1997-12-02 | Hoeganaes Ab | Lubricant for metallurgical powder compositions |
| ATE534298T1 (de) | 1997-12-22 | 2011-12-15 | Novozymes As | Kohlenhydratoxidase sowie verwendung derselben beim backen |
| EP1183373A1 (en) * | 1999-05-17 | 2002-03-06 | Novozymes A/S | Polypeptides with protein disulfide reducing properties |
| CN1425068B (zh) | 2000-03-14 | 2011-05-18 | 诺维信公司 | 在制备多肽的方法中有效的真菌转录激活因子 |
| EP1301080B1 (en) | 2000-07-06 | 2011-09-14 | Novozymes A/S | Method of preparing a dough, or a baked product made from a dough, with addition of lipolytic enzymes |
| DK1326497T3 (da) | 2000-10-12 | 2006-09-18 | Novozymes As | Fremstilling af et bagt produkt af dej |
| KR100414182B1 (ko) * | 2001-07-02 | 2004-01-07 | 대한민국 | 누에 배양세포로부터 분리한 프로테인 디설피드이소머레이즈를 코딩하는 ｃＤＮＡ 유전자의 염기서열 및그의 연역 아미노산 |
| EP2295556B1 (en) | 2002-01-16 | 2014-10-29 | Novozymes A/S | Lipolytic enzymes variants and methods for their production |
| BR0311205A (pt) | 2002-05-21 | 2005-03-15 | Dsm Ip Assets Bv | Fosfolipases e seus usos |
| DK2338986T3 (en) | 2002-08-19 | 2015-01-19 | Dsm Ip Assets Bv | Novel lipases and uses thereof |
| US20040203132A1 (en) * | 2003-02-28 | 2004-10-14 | Cognetix, Inc. | Conus protein disulfide isomerase |
| KR20100014954A (ko) | 2007-03-09 | 2010-02-11 | 다니스코 유에스 인크. | 호알칼리성 바실러스 종 α-아밀라아제 변이체, α-아밀라아제 변이체를 함유하는 조성물 및 사용 방법 |
| CN101657537B (zh) | 2007-03-14 | 2013-06-19 | 丹尼斯科美国公司 | 里氏木霉α-淀粉酶增强玉米淀粉的糖化 |
| DK2554666T3 (en) | 2008-01-02 | 2015-11-02 | Danisco Us Inc | PROCEDURE FOR OBTAINING ETHANOL WITHOUT glucoamylase USING PSEUDOMONAS saccharophila G4 amylase AND VARIATIONS THEREOF |
| JP5706695B2 (ja) * | 2008-03-04 | 2015-04-22 | ダニスコ・アクティーゼルスカブＤａｎｉｓｃｏ Ａ／Ｓ | 遊離チオールの酵素的除去によるタンパク質性基質の酵素処理の改善 |
| EP2103219A1 (en) | 2008-03-10 | 2009-09-23 | Novozymes A/S | Dough with fructan and fructan-degrading enzyme |
| WO2009149283A1 (en) | 2008-06-06 | 2009-12-10 | Danisco Us Inc. | Saccharification enzyme composition |
| CN102112621A (zh) | 2008-06-06 | 2011-06-29 | 丹尼斯科美国公司 | 用来自枯草芽孢杆菌的α-淀粉酶从淀粉产生葡萄糖 |
| DK2297313T3 (en) | 2008-06-06 | 2015-06-08 | Danisco Us Inc | ALPHA AMYLASE VARIETIES OF BACILLUS SUBTILIS AND METHODS OF USING IT |
| FR2933773B1 (fr) * | 2008-07-10 | 2013-02-15 | Biomerieux Sa | Procede de dosage de la proteine disulfide isomerase pour le diagnostic in vitro du cancer colorectal |
| EP2406372B1 (en) | 2009-03-10 | 2017-08-23 | DSM IP Assets B.V. | Pregastric esterase and derivatives thereof |
| EP3620518B1 (en) | 2009-05-19 | 2021-08-18 | DuPont Nutrition Biosciences ApS | Amylase polypeptide |
| JP2013503612A (ja) | 2009-09-03 | 2013-02-04 | ディーエスエム アイピー アセッツ ビー．ブイ． | Ｓｓｌ代替物としてのベーキング酵素組成物 |
| DE102009051013A1 (de) | 2009-10-28 | 2011-06-09 | Ab Enzymes Gmbh | Klonierung, Expression und Verwendung saurer Phospholipasen |
| EP2486799A1 (en) | 2011-02-14 | 2012-08-15 | DSM IP Assets B.V. | Method to produce cake with lipolytic enzyme and alpha-amylase |
| AU2012328562A1 (en) | 2011-10-28 | 2014-03-13 | Danisco Us Inc. | Variant maltohexaose-forming alpha-amylase variants |
| EP2620496B1 (en) | 2012-01-30 | 2015-06-03 | DSM IP Assets B.V. | Alpha-amylase |
| CA2870830A1 (en) | 2012-05-11 | 2013-11-14 | Danisco Us Inc. | Use of alpha-amylase from aspergillus clavatus for saccharification |
| EP4026902B1 (en) | 2012-06-08 | 2025-04-16 | Danisco US Inc. | Variant alpha amylases with enhanced activity on starch polymers |
| CN104583412A (zh) | 2012-08-16 | 2015-04-29 | 丹尼斯科美国公司 | 采用棒曲霉α-淀粉酶和支链淀粉酶由淀粉制备葡萄糖的方法 |
| WO2014081622A1 (en) | 2012-11-20 | 2014-05-30 | Danisco Us Inc. | Amylase with maltogenic properties |
| JP6499081B2 (ja) | 2012-12-11 | 2019-04-10 | ダニスコ・ユーエス・インク | アスペルギルス・フミガタス（Ａｓｐｅｒｇｉｌｌｕｓｆｕｍｉｇａｔｕｓ）由来のグルコアミラーゼを発現するトリコデルマ・レーシ（Ｔｒｉｃｈｏｄｅｒｍａｒｅｅｓｅｉ）宿主細胞、及びその使用方法 |
| EP2931911A1 (en) | 2012-12-14 | 2015-10-21 | Danisco US Inc. | Method of using alpha-amylase from aspergillus fumigatus and isoamylase for saccharification |
| CN104903461A (zh) | 2012-12-20 | 2015-09-09 | 丹尼斯科美国公司 | 将支链淀粉酶和来自土曲霉的α-淀粉酶用于糖化的方法 |
| WO2014099525A1 (en) | 2012-12-21 | 2014-06-26 | Danisco Us Inc. | Paenibacillus curdlanolyticus amylase, and methods of use, thereof |
| DK2935575T3 (en) | 2012-12-21 | 2018-07-23 | Danisco Us Inc | ALPHA-amylase variants |
| DK3336183T4 (da) | 2013-03-11 | 2025-06-10 | Danisco Us Inc | Kombinatoriske alfa-amylasevarianter |
| WO2014200658A1 (en) | 2013-06-13 | 2014-12-18 | Danisco Us Inc. | Alpha-amylase from promicromonospora vindobonensis |
| WO2014200656A1 (en) | 2013-06-13 | 2014-12-18 | Danisco Us Inc. | Alpha-amylase from streptomyces umbrinus |
| WO2014200657A1 (en) | 2013-06-13 | 2014-12-18 | Danisco Us Inc. | Alpha-amylase from streptomyces xiamenensis |
| WO2014204596A1 (en) | 2013-06-17 | 2014-12-24 | Danisco Us Inc. | Alpha-amylase from bacillaceae family member |
| EP3060659B1 (en) | 2013-10-03 | 2019-05-29 | Danisco US Inc. | Alpha-amylases from exiguobacterium, and methods of use, thereof |
| WO2015050724A1 (en) | 2013-10-03 | 2015-04-09 | Danisco Us Inc. | Alpha-amylases from a subset of exiguobacterium, and methods of use, thereof |
| WO2015077126A1 (en) | 2013-11-20 | 2015-05-28 | Danisco Us Inc. | Variant alpha-amylases having reduced susceptibility to protease cleavage, and methods of use, thereof |
| WO2015094809A1 (en) | 2013-12-19 | 2015-06-25 | Danisco Us Inc. | Chimeric fungal alpha-amylases comprising carbohydrate binding module and the use thereof |
| WO2017050652A1 (en) | 2015-09-25 | 2017-03-30 | Dsm Ip Assets B.V. | Asparaginase |
| WO2017100720A1 (en) | 2015-12-09 | 2017-06-15 | Danisco Us Inc. | Alpha-amylase combinatorial variants |
| WO2017173190A2 (en) | 2016-04-01 | 2017-10-05 | Danisco Us Inc. | Alpha-amylases, compositions & methods |
| WO2017173324A2 (en) | 2016-04-01 | 2017-10-05 | Danisco Us Inc. | Alpha-amylases, compositions & methods |
| WO2018114938A1 (en) | 2016-12-21 | 2018-06-28 | Dsm Ip Assets B.V. | Lipolytic enzyme variants |
| WO2018114912A1 (en) | 2016-12-21 | 2018-06-28 | Dsm Ip Assets B.V. | Lipolytic enzyme variants |
| WO2018114941A1 (en) | 2016-12-21 | 2018-06-28 | Dsm Ip Assets B.V. | Lipolytic enzyme variants |
| WO2018114940A1 (en) | 2016-12-21 | 2018-06-28 | Dsm Ip Assets B.V. | Lipolytic enzyme variants |
| BR112020025589A2 (pt) | 2018-06-19 | 2021-03-23 | Dsm Ip Assets B.V. | variantes de enzima lipolítica |
| CA3238467A1 (en) | 2021-11-18 | 2023-05-25 | Veli Alkan | High performance alpha-amylases for starch liquefaction |
| JP2025520009A (ja) | 2022-05-16 | 2025-07-01 | ディーエスエム アイピー アセッツ ビー．ブイ． | 脂肪分解酵素変異体 |
| WO2024002785A1 (en) | 2022-06-29 | 2024-01-04 | Dsm Ip Assets B.V. | Use of peptidylarginine deiminase to obtain an improved baked good |
| WO2025012325A1 (en) | 2023-07-11 | 2025-01-16 | Dsm Ip Assets B.V. | Protein arginine deiminase |
| WO2025132821A1 (en) | 2023-12-19 | 2025-06-26 | Firmenich Sa | Comestible products having high fiber and low sugar |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8626356D0 (en) * | 1986-11-04 | 1986-12-03 | Reading University Of | Treatment of hair |
| GB8626357D0 (en) * | 1986-11-04 | 1986-12-03 | Reading University Of | Treatment of wool textiles |
| WO1988005816A1 (fr) * | 1987-01-28 | 1988-08-11 | Takeda Chemical Industries, Ltd. | Polypeptide |
| IL86455A0 (en) * | 1987-06-01 | 1988-11-15 | Takeda Chemical Industries Ltd | Polypeptide and production thereof |
| US4894340A (en) * | 1987-12-21 | 1990-01-16 | Suomen Sokeri Oy | Microbial sulfhydryl oxidase and method |
| US5496719A (en) * | 1992-05-27 | 1996-03-05 | Kabushiki Kaisha Toyota Chuo Kenkyusho | Polypeptide from Humicola insolens possessing protein disulfide isomerase activity gene encoding the same |
| US6291205B1 (en) * | 1992-06-12 | 2001-09-18 | Merck & Co., Inc. | Method of increasing production of disulfide bonded recombinant proteins by saccharomyces cerevisiae |
| DK76893D0 (OSRAM) * | 1993-06-28 | 1993-06-28 | Novo Nordisk As |
-
1993
- 1993-06-28 DK DK93768A patent/DK76893D0/da not_active Application Discontinuation
-
1994
- 1994-06-28 EP EP94919570A patent/EP0708825A1/en not_active Withdrawn
- 1994-06-28 US US08/557,122 patent/US5879664A/en not_active Expired - Fee Related
- 1994-06-28 WO PCT/DK1994/000266 patent/WO1995000636A1/en not_active Ceased
- 1994-06-28 AU AU70684/94A patent/AU7068494A/en not_active Abandoned
- 1994-06-28 JP JP7502358A patent/JPH09500014A/ja not_active Ceased
-
1999
- 1999-03-04 US US09/262,666 patent/US6346244B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US6346244B1 (en) | 2002-02-12 |
| DK76893D0 (OSRAM) | 1993-06-28 |
| AU7068494A (en) | 1995-01-17 |
| EP0708825A1 (en) | 1996-05-01 |
| WO1995000636A1 (en) | 1995-01-05 |
| US5879664A (en) | 1999-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5879664A (en) | Fungal protein disulfide isomerase | |
| JP3535162B2 (ja) | α−ガラクトシダーゼ酵素 | |
| JP3307947B2 (ja) | キシラナーゼを含有する動物飼料添加剤 | |
| JP5520828B2 (ja) | 改変される特徴を有するバシルス種（Ｂａｃｉｌｌｕｓｓｐ．）ＴＳ‐２３アルファ‐アミラーゼ変異体 | |
| US5879921A (en) | Recombinant expression of a glucose oxidase from a cladosporium strain | |
| WO1996022366A1 (en) | Transglutaminases from oomycetes | |
| US5834280A (en) | Glucose oxidases obtained from a cladosporium | |
| EP0804558B1 (en) | Tripeptidyl aminopeptidase | |
| JP4267696B2 (ja) | ガラクタナーゼ活性を有する酵素 | |
| US5681715A (en) | Process for preparing lipases | |
| CN112410322A (zh) | 一种地衣芽孢杆菌β-甘露聚糖酶突变体及应用 | |
| US6602700B1 (en) | Phenolic acid esterases, coding sequences and methods | |
| CZ304969B6 (cs) | Způsob přípravy rekombinantní proteinázy K, vektor obsahující DNA kódující zymogenní prekurzor proteinázy K a kvasinková hostitelská buňka transformovaná tímto vektorem | |
| WO2000070064A1 (en) | Polypeptides with protein disulfide reducing properties | |
| WO1995001425A1 (en) | Compositions comprising protein disulfide redox agents | |
| Kainuma et al. | Purification and characterization of protein disulfide isomerase from soybean | |
| CN112877306B (zh) | 一种超耐热葡萄糖氧化酶AtGOD及其基因和应用 | |
| WO2023176943A1 (ja) | 改変型プロテイングルタミナーゼ | |
| TW200401033A (en) | Modified phytases | |
| FR2786784A1 (fr) | FRAGMENT D'ADN CODANT POUR LA XYLANASE THERMOSTABLE XynA DE THERMOASCUS | |
| JPH07504807A (ja) | プロテアーゼ安定性タンパク質 | |
| CN101084306B (zh) | 过量表达和纯化的无花果曲霉氧化酶及其编码核酸 | |
| AU695995C (en) | Transglutaminases from oomycetes | |
| Matsumoto et al. | High-level production of recombinant glutamic acid-specific protease from Bacilllus licheniformis in Bacillus subtilis expression system | |
| JPH10327886A (ja) | コムギ種子に由来するシステインプロテイナーゼをコードするｄｎａ、該ｄｎａを含む形質転換大腸菌、及び該菌から発現する組換えシステインプロテイナーゼ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20031224 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20040120 |